Advancing Lymphoma Treatment in Singapore: Personalised Cancer Care at CFCH
Lymphoma, or cancer of the lymph glands is one of the most common types of cancers in Singapore. Diffuse large B-cell lymphoma (DLBCL) is a significant form of lymphoma. A diagnosis of lymphoma, especially Diffuse Large B-Cell Lymphoma (DLBCL), can be overwhelming. But for patients with lymphoma in Singapore, hope for a cure is real […]
Older Patients With Relapsed Refractory Diffuse Large B cell Lymphoma Treated With Axi-cel Have Better Outcomes Compared With Chemoimmunotherapy
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and patients with relapsed or refractory disease often have poor prognoses. This is particularly true for older adults, with comorbidities along with an increased risk for mortality and severe toxicity from intensive salvage chemoimmunotherapy (CIT) and may not be eligible for autologous […]
New Advances Enhance Blood Cancer Treatment Options
Media CAR T-cell the…
CAR-T Cell Therapy: A New Treatment for Agreesive Blood Cancers
Media Read From Sour…